×
ADVERTISEMENT

neuromuscular blockade

Up for Debate: What’s The Ideal Time to Reverse Neuromuscular Blockade?

The timing of neuromuscular blockade reversal, specifically as it relates to transporting patients from the OR to ...

MARCH 6, 2024

ASA, ESAIC: Quantitative Monitoring Essential for Neuromuscular Blockade

Patients receiving neuromuscular blocking agents during anesthesia should be monitored using quantitative ...

AUGUST 7, 2023

ASA’s Guidelines for NMB Monitoring: A Dissenting View—And a Response

The new guidelines for monitoring neuromuscular blockade seem to be a solution, and a very costly one at that, in ...

JUNE 13, 2023

Guidelines Issued by ASA for Monitoring Neuromuscular Blockade

The release of a new set of guidelines by the American Society of Anesthesiologists aims to reduce residual ...

FEBRUARY 6, 2023

Study Supports Sugammadex As Reversal Agent for Neuromuscular Blockade

A new meta-analysis has confirmed the suspicions of many clinicians about the relative effects of sugammadex and ...

DECEMBER 29, 2022

Acceleromyography: There’s an App for That

It’s possible to jury-rig a train-of-four (TOF) monitor armed only with your phone.

MAY 24, 2022

Factors Increasing Need for Additional Reversal in Peds Described

Researchers have identified a series of risk factors for residual neuromuscular blockade after rocuronium ...

MAY 20, 2022

‘60-Second Abstracts’: New App Simulates OR Decision Making, Measures Outcomes in Dollars

In the near future, the development of a simulated anesthesia app may help anesthesiologists save time and money in ...

MARCH 26, 2022

New App Simulates OR Decision Making, Measures Outcomes in Dollars

Researchers say that the panoramic, screen-based simulator is particularly adept at assessing the cost of ...

MARCH 14, 2022

Adverse Effects of NMBAs Seen in ARDS Patients

The use of NMBAs in patients with ARDS is associated with increased in-hospital mortality, prolonged mechanical ...

DECEMBER 14, 2020

Lower Doses of Sugammadex May Still Be Effective

Lower doses of sugammadex may not result in clinically significant delays in recovery from neuromuscular blockade.

AUGUST 14, 2020

Neuromuscular Block Protocol Decreases Residual Blockade

Use of rocuronium, neostigmine and sugammadex is linked to low incidence of post-op residual neuromuscular ...

MARCH 23, 2020

Load more